Clinical trial Recruiting at 1 site Observational Ages 0 and up

Registry and clinical study for Wolfram syndrome and related disorders

Official title: Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study

Run by Washington University School of Medicine · NCT02841553 · Data updated 2026-11-12

This study is trying to gather information from people with Wolfram syndrome to better understand the condition and its effects, while also looking for specific gene mutations.

Quick facts

Study typeObservational
Ages0 Years and up
SexAll
Enrollment5000 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedJuly 2011
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedDecember 23, 2025
Trial IDNCT02841553 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with Wolfram syndrome, including minors, who have access to the Internet.

Probably not a fit

Patients without a diagnosis of Wolfram syndrome or those who do not meet the eligibility criteria will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish and maintain an international registry of patients diagnosed with Wolfram syndrome, focusing on collecting clinical information to better understand the natural history and metabolic phenotypes associated with the condition. Participants will provide blood samples for genetic analysis to identify mutations in the WFS1 gene, which is linked to the syndrome. The study will analyze data on the onset and progression of symptoms such as diabetes mellitus, optic nerve atrophy, and other related complications. The findings may offer insights into the complexities of diabetes and related disorders.

Why it matters

Potential benefit: If successful, this study could enhance understanding of Wolfram syndrome and improve management strategies for patients with diabetes and related conditions.

How similar studies have gone: While the approach of establishing a registry for rare genetic disorders is not novel, the specific focus on Wolfram syndrome and its genetic underpinnings is relatively unique and may provide new insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Any patient worldwide with a diagnosis of Wolfram syndrome and with access to the Internet can be enrolled in the Registry. Since the disease usually manifests in the first decade of life and tends to have an inevitably progressive course, participation of minors is important for establishing the natural course of the disease.

Inclusion Criteria:

Major Criteria

* Diabetes mellitus \<16 yrs
* Optic atrophy \<16 yrs

Minor Criteria

* Diabetes insipidus
* Diabetes mellitus \>16yrs
* Optic atrophy \>16 yrs
* Sensorineural deafness
* Neurological signs (ataxia, epilepsy, cognitive impairment)
* Renal tract abnormalities (structural or functional)
* 1 loss of function mutation in WFS1/CISD2 AND/OR family history of Wolfram syndrome

Minimum Required

* 2 major OR
* 1 major plus 2 minor criteria OR
* 2 pathological WFS1 or CISD2 mutations are identified

Other variable suggestive evidence

* Hypogonadism (males)
* An absence of type 1 diabetes auto-antibodies
* Bilateral cataracts
* Psychiatric disorder
* Gastrointestinal

Exclusion Criteria:

Inability of a patient and/or a guardian to obtain help with translation and thus, inability to understand questionnaire.

Parent, Sibs, and Spouses:

\- Parents, sibs, and spouses that are unaffected will be recruited as controls. Inclusion criterion is having the unaffected status and exclusion criterion is if the person cannot understand the Informed Consent Document.

Where it's running

  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.